Renal and Rheumatology Division, Internal Medicine Department, Okinawa Nanbu Prefectural Medical Center and Children's Medical Center, Okinawa, Japan,
Renal Division and Blood Purification Center, University of the Ryukyus, Okinawa, Japan.
Am J Nephrol. 2021;52(2):108-118. doi: 10.1159/000513951. Epub 2021 Mar 23.
Risk factors of mortality in chronic hemodialysis patients have not yet been sufficiently evaluated. In particular, chronological transits and interactions of the impact of risk factors have rarely been described.
This study is a post hoc analysis of the participants in the Olme-sartan Clinical Trial in Okinawan Patients under OKIDS (OCTOPUS) study conducted between June 2006 and June 2011. We additionally followed up on the prognosis of the participants until July 31, 2018. Standardized univariable and multivariable Cox regression analyses were used to evaluate the influences of the participants' baseline characteristics on all-cause mortality. We also evaluated chronological changes in the impacts of risk factors, interactions among predictors, and the influence of missing values using sensitivity analyses.
Of the 469 original trial participants, 461 participants were evaluated. The median time of follow-up was 10.2 years. A total of 211 (45.8%) participants were deceased. The leading causes of death were infection (n = 72, 34.1%) and cardiovascular disease (n = 66, 31.3%). Univariate and multivariate Cox regression analyses revealed that the impact of diabetes mellitus, history of coronary intervention, and hypoalbuminemia were significant risk factors for mortality during the whole follow-up period. During the early follow-up period (≤3 years), standardized univariate Cox regression analyses revealed that history of amputation (hazard ratio [HR] = 4.61, p < 0.001), lower dry weight, higher cardiothoracic ratio, and lower potassium levels were statistically significant risks. In those who survived for longer than 3 years, a history of stroke (HR = 1.73, p = 0.006), higher systolic blood pressure, lower serum sodium levels, and higher levels of hemoglobin, and serum phosphate were significant risks. We also observed a stable interaction between the impacts of serum phosphate and albumin on all-cause mortality.
In chronic hemodialysis patients, targets to improve the short-term prognosis and long-term prognosis are not equivalent. Hyperphosphatemia was a significant risk factor for the all-cause mortality among patients with normal serum albumin levels but not among patients with compromised albumin levels.
慢性血液透析患者的死亡风险因素尚未得到充分评估。特别是,风险因素的影响的时间转移和相互作用很少被描述。
本研究是 2006 年 6 月至 2011 年 6 月期间进行的冲绳患者 Olme-sartan 临床试验(OCTOPUS 研究)参与者的事后分析。我们还对参与者的预后进行了随访,直到 2018 年 7 月 31 日。采用标准化单变量和多变量 Cox 回归分析评估参与者基线特征对全因死亡率的影响。我们还使用敏感性分析评估了风险因素影响的时间变化、预测因子之间的相互作用以及缺失值的影响。
在最初的 469 名试验参与者中,有 461 名参与者被评估。中位随访时间为 10.2 年。共有 211 名(45.8%)参与者死亡。死亡的主要原因是感染(n=72,34.1%)和心血管疾病(n=66,31.3%)。单变量和多变量 Cox 回归分析显示,糖尿病、冠状动脉介入治疗史和低白蛋白血症是整个随访期间死亡的重要危险因素。在早期随访期间(≤3 年),标准化单变量 Cox 回归分析显示,截肢史(风险比[HR]=4.61,p<0.001)、较低的干体重、较高的心胸比和较低的钾水平是统计学上显著的风险。在存活时间超过 3 年的患者中,中风史(HR=1.73,p=0.006)、较高的收缩压、较低的血清钠水平、较高的血红蛋白和血清磷酸盐水平是显著的风险。我们还观察到血清磷酸盐和白蛋白对全因死亡率的影响之间存在稳定的相互作用。
在慢性血液透析患者中,改善短期预后和长期预后的目标并不等同。高磷血症是血清白蛋白水平正常患者全因死亡率的显著危险因素,但不是血清白蛋白水平受损患者的危险因素。